Organization
Monash University, CabriniHealth, Melbourne, Australia
1 abstract
Abstract
APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (156-WEEK) IMPROVEMENTS IN BASDAI IN PSORIATIC ARTHRITIS PATIENTS: POOLED RESULTS FROM 3 PHASE III, RANDOMIZED, CONTROLLED TRIALS Org: Swedish Medical Center and University of Washington School of Medicine, Seattle, United States, NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals and University of Leeds, Leeds, United Kingdom, Clinical Research Centre Ltd, Tartu, Estonia, UZ Gent, Gent, Belgium, Schön Klinik Hamburg Eilbek, Hamburg, Germany,